Global Cell-Surface Markers Market
Global Cell-Surface Markers Market

Cell-Surface Markers Comprehensive Study by Type (Antibody, PCR Array), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology), Hospitals), Reagent Type (Flow Cytometer, Hematology Analyzers, Reagents and Kits), Source (Mice, Rats), Cell Type (T Cells, B Cells, NK Cell) Players and Region - Global Market Outlook to 2026

Cell-Surface Markers Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 248 Pages 216 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Cell-Surface Markers Market Scope?
Cell surface markers are special proteins and carbohydrates that are bound to the cell membrane. While some proteins have the job of facilitating the transport of molecules across the membrane, cell surface markers play a role in intercellular communication and recognition. In short, cell surface markers are like a fingerprint that is specific for each type of cell and can be identified by the types of markers present on the membrane. Cell surface markers are generally used so as to classify cells according to their markers. This data is in turn used to identify different types of cells, from cancer cells to stem cells to cells infected with HIV. Cell surface markers also offer the potential to aid drug discovery and, in particular, personalized medicine. With the ability to identify individual cells using surface markers, scientists are beginning to make breakthroughs in the development of new drugs.

The Cell-Surface Markers market study is being classified by Type (Antibody and PCR Array), by Application (Research [Stem Cell, Immunology], Clinical [Oncology, Hematology] and Hospitals) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Cell-Surface Markers market throughout the predicted period.

Abbott Laboratories (United States), QIAGEN (Germany), Beckman Coulter (United States), BD (United States), Bio-Rad Laboratories (United States), Grifols (Spain), Immucor, Inc. (United States), Janssen Pharmaceutica (Belgium), Nihon Kohden (Japan), Roche Holding AG (Switzerland), Siemens (Germany), Sysmex Corporation (Japan) and Thermo Fisher Scientific (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Cell-Surface Markers market by Type, Application and Region.

On the basis of geography, the market of Cell-Surface Markers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In 2018, Thermo Fisher Scientific had acquired the Advanced Bioprocessing business of Becton, Dickinson and Company. This would hereby be integrated into the Life Sciences Solutions segment of Thermo Fisher.
In 2018, QIAGEN had opened its new shared service center in Manila—QIAGEN Business Services (QBS). QBS would provide services related to supply chain management, customer care, accounting, technical services, and other sales support activities to QIAGEN'S global operations.


Influencing Market Trend
  • The Rising Public-Private Funding For Cell Surface Marker-Based Research
  • Availability of Reagents and Staining Dyes That Are Useful In Specific Cytological Protocols
  • The Growing Use of Cell Surface Markers in Cancer, Stem Cell, and HIV Research

Market Drivers
  • The Increasing Funding For Life Sciences Research
  • High Global Prevalence of Cancer
  • Increased Use in Diagnostics
  • Increasing Demand for Precision Medicine
  • Growth in Stem Cell and Neurobiology Research
  • Rising Incidence of Different Cell-Associated and Oncology Diseases

Opportunities
  • Technological Advances Related To Increased Throughput and Automation
  • Advancements in Monoclonal Antibody Production and Generation of Cell-Specific Antibodies for Diagnostic and Prognostic Usage
  • The Increasing Number of Life Sciences Research Activities and Government Initiatives

Restraints
  • High Cost of Instruments

Challenges
  • Complexity of Techniques


Key Target Audience
Providers of Cell Surface Marker, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Antibody
  • PCR Array
By Application
  • Research [Stem Cell, Immunology]
  • Clinical [Oncology, Hematology]
  • Hospitals
By Reagent Type
  • Flow Cytometer
  • Hematology Analyzers
  • Reagents and Kits

By Source
  • Mice
  • Rats

By Cell Type
  • T Cells
  • B Cells
  • NK Cell

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Funding For Life Sciences Research
      • 3.2.2. High Global Prevalence of Cancer
      • 3.2.3. Increased Use in Diagnostics
      • 3.2.4. Increasing Demand for Precision Medicine
      • 3.2.5. Growth in Stem Cell and Neurobiology Research
      • 3.2.6. Rising Incidence of Different Cell-Associated and Oncology Diseases
    • 3.3. Market Challenges
      • 3.3.1. Complexity of Techniques
    • 3.4. Market Trends
      • 3.4.1. The Rising Public-Private Funding For Cell Surface Marker-Based Research
      • 3.4.2. Availability of Reagents and Staining Dyes That Are Useful In Specific Cytological Protocols
      • 3.4.3. The Growing Use of Cell Surface Markers in Cancer, Stem Cell, and HIV Research
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cell-Surface Markers, by Type, Application, Reagent Type, Source, Cell Type and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cell-Surface Markers (Value)
      • 5.2.1. Global Cell-Surface Markers by: Type (Value)
        • 5.2.1.1. Antibody
        • 5.2.1.2. PCR Array
      • 5.2.2. Global Cell-Surface Markers by: Application (Value)
        • 5.2.2.1. Research [Stem Cell, Immunology]
        • 5.2.2.2. Clinical [Oncology, Hematology]
        • 5.2.2.3. Hospitals
      • 5.2.3. Global Cell-Surface Markers by: Reagent Type (Value)
        • 5.2.3.1. Flow Cytometer
        • 5.2.3.2. Hematology Analyzers
        • 5.2.3.3. Reagents and Kits
      • 5.2.4. Global Cell-Surface Markers by: Source (Value)
        • 5.2.4.1. Mice
        • 5.2.4.2. Rats
      • 5.2.5. Global Cell-Surface Markers by: Cell Type (Value)
        • 5.2.5.1. T Cells
        • 5.2.5.2. B Cells
        • 5.2.5.3. NK Cell
      • 5.2.6. Global Cell-Surface Markers Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Cell-Surface Markers (Price)
      • 5.3.1. Global Cell-Surface Markers by: Type (Price)
  • 6. Cell-Surface Markers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. QIAGEN (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BD (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Grifols (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Immucor, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Janssen Pharmaceutica (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nihon Kohden (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Roche Holding AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Siemens (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Sysmex Corporation (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Thermo Fisher Scientific (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Cell-Surface Markers Sale, by Type, Application, Reagent Type, Source, Cell Type and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cell-Surface Markers (Value)
      • 7.2.1. Global Cell-Surface Markers by: Type (Value)
        • 7.2.1.1. Antibody
        • 7.2.1.2. PCR Array
      • 7.2.2. Global Cell-Surface Markers by: Application (Value)
        • 7.2.2.1. Research [Stem Cell, Immunology]
        • 7.2.2.2. Clinical [Oncology, Hematology]
        • 7.2.2.3. Hospitals
      • 7.2.3. Global Cell-Surface Markers by: Reagent Type (Value)
        • 7.2.3.1. Flow Cytometer
        • 7.2.3.2. Hematology Analyzers
        • 7.2.3.3. Reagents and Kits
      • 7.2.4. Global Cell-Surface Markers by: Source (Value)
        • 7.2.4.1. Mice
        • 7.2.4.2. Rats
      • 7.2.5. Global Cell-Surface Markers by: Cell Type (Value)
        • 7.2.5.1. T Cells
        • 7.2.5.2. B Cells
        • 7.2.5.3. NK Cell
      • 7.2.6. Global Cell-Surface Markers Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Cell-Surface Markers (Price)
      • 7.3.1. Global Cell-Surface Markers by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cell-Surface Markers: by Type(USD Million)
  • Table 2. Cell-Surface Markers Antibody , by Region USD Million (2015-2020)
  • Table 3. Cell-Surface Markers PCR Array , by Region USD Million (2015-2020)
  • Table 4. Cell-Surface Markers: by Application(USD Million)
  • Table 5. Cell-Surface Markers Research [Stem Cell, Immunology] , by Region USD Million (2015-2020)
  • Table 6. Cell-Surface Markers Clinical [Oncology, Hematology] , by Region USD Million (2015-2020)
  • Table 7. Cell-Surface Markers Hospitals , by Region USD Million (2015-2020)
  • Table 8. Cell-Surface Markers: by Reagent Type(USD Million)
  • Table 9. Cell-Surface Markers Flow Cytometer , by Region USD Million (2015-2020)
  • Table 10. Cell-Surface Markers Hematology Analyzers , by Region USD Million (2015-2020)
  • Table 11. Cell-Surface Markers Reagents and Kits , by Region USD Million (2015-2020)
  • Table 12. Cell-Surface Markers: by Source(USD Million)
  • Table 13. Cell-Surface Markers Mice , by Region USD Million (2015-2020)
  • Table 14. Cell-Surface Markers Rats , by Region USD Million (2015-2020)
  • Table 15. Cell-Surface Markers: by Cell Type(USD Million)
  • Table 16. Cell-Surface Markers T Cells , by Region USD Million (2015-2020)
  • Table 17. Cell-Surface Markers B Cells , by Region USD Million (2015-2020)
  • Table 18. Cell-Surface Markers NK Cell , by Region USD Million (2015-2020)
  • Table 19. South America Cell-Surface Markers, by Country USD Million (2015-2020)
  • Table 20. South America Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 21. South America Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 22. South America Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 23. South America Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 24. South America Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 25. Brazil Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 26. Brazil Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 27. Brazil Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 28. Brazil Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 29. Brazil Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 30. Argentina Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 31. Argentina Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 32. Argentina Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 33. Argentina Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 34. Argentina Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 35. Rest of South America Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 36. Rest of South America Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 37. Rest of South America Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 38. Rest of South America Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 39. Rest of South America Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 40. Asia Pacific Cell-Surface Markers, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 42. Asia Pacific Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 43. Asia Pacific Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 44. Asia Pacific Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 45. Asia Pacific Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 46. China Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 47. China Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 48. China Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 49. China Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 50. China Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 51. Japan Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 52. Japan Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 53. Japan Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 54. Japan Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 55. Japan Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 56. India Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 57. India Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 58. India Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 59. India Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 60. India Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 61. South Korea Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 62. South Korea Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 63. South Korea Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 64. South Korea Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 65. South Korea Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 66. Taiwan Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 67. Taiwan Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 68. Taiwan Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 69. Taiwan Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 70. Taiwan Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 71. Australia Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 72. Australia Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 73. Australia Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 74. Australia Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 75. Australia Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 80. Rest of Asia-Pacific Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 81. Europe Cell-Surface Markers, by Country USD Million (2015-2020)
  • Table 82. Europe Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 83. Europe Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 84. Europe Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 85. Europe Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 86. Europe Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 87. Germany Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 88. Germany Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 89. Germany Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 90. Germany Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 91. Germany Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 92. France Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 93. France Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 94. France Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 95. France Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 96. France Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 97. Italy Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 98. Italy Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 99. Italy Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 100. Italy Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 101. Italy Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 102. United Kingdom Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 103. United Kingdom Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 104. United Kingdom Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 105. United Kingdom Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 106. United Kingdom Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 107. Netherlands Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 108. Netherlands Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 109. Netherlands Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 110. Netherlands Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 111. Netherlands Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 112. Rest of Europe Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 113. Rest of Europe Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 114. Rest of Europe Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 115. Rest of Europe Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 116. Rest of Europe Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 117. MEA Cell-Surface Markers, by Country USD Million (2015-2020)
  • Table 118. MEA Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 119. MEA Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 120. MEA Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 121. MEA Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 122. MEA Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 123. Middle East Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 124. Middle East Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 125. Middle East Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 126. Middle East Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 127. Middle East Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 128. Africa Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 129. Africa Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 130. Africa Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 131. Africa Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 132. Africa Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 133. North America Cell-Surface Markers, by Country USD Million (2015-2020)
  • Table 134. North America Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 135. North America Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 136. North America Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 137. North America Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 138. North America Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 139. United States Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 140. United States Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 141. United States Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 142. United States Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 143. United States Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 144. Canada Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 145. Canada Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 146. Canada Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 147. Canada Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 148. Canada Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 149. Mexico Cell-Surface Markers, by Type USD Million (2015-2020)
  • Table 150. Mexico Cell-Surface Markers, by Application USD Million (2015-2020)
  • Table 151. Mexico Cell-Surface Markers, by Reagent Type USD Million (2015-2020)
  • Table 152. Mexico Cell-Surface Markers, by Source USD Million (2015-2020)
  • Table 153. Mexico Cell-Surface Markers, by Cell Type USD Million (2015-2020)
  • Table 154. Cell-Surface Markers: by Type(USD/Units)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Cell-Surface Markers: by Type(USD Million)
  • Table 169. Cell-Surface Markers Antibody , by Region USD Million (2021-2026)
  • Table 170. Cell-Surface Markers PCR Array , by Region USD Million (2021-2026)
  • Table 171. Cell-Surface Markers: by Application(USD Million)
  • Table 172. Cell-Surface Markers Research [Stem Cell, Immunology] , by Region USD Million (2021-2026)
  • Table 173. Cell-Surface Markers Clinical [Oncology, Hematology] , by Region USD Million (2021-2026)
  • Table 174. Cell-Surface Markers Hospitals , by Region USD Million (2021-2026)
  • Table 175. Cell-Surface Markers: by Reagent Type(USD Million)
  • Table 176. Cell-Surface Markers Flow Cytometer , by Region USD Million (2021-2026)
  • Table 177. Cell-Surface Markers Hematology Analyzers , by Region USD Million (2021-2026)
  • Table 178. Cell-Surface Markers Reagents and Kits , by Region USD Million (2021-2026)
  • Table 179. Cell-Surface Markers: by Source(USD Million)
  • Table 180. Cell-Surface Markers Mice , by Region USD Million (2021-2026)
  • Table 181. Cell-Surface Markers Rats , by Region USD Million (2021-2026)
  • Table 182. Cell-Surface Markers: by Cell Type(USD Million)
  • Table 183. Cell-Surface Markers T Cells , by Region USD Million (2021-2026)
  • Table 184. Cell-Surface Markers B Cells , by Region USD Million (2021-2026)
  • Table 185. Cell-Surface Markers NK Cell , by Region USD Million (2021-2026)
  • Table 186. South America Cell-Surface Markers, by Country USD Million (2021-2026)
  • Table 187. South America Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 188. South America Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 189. South America Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 190. South America Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 191. South America Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 192. Brazil Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 193. Brazil Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 194. Brazil Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 195. Brazil Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 196. Brazil Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 197. Argentina Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 198. Argentina Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 199. Argentina Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 200. Argentina Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 201. Argentina Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 202. Rest of South America Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 203. Rest of South America Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 204. Rest of South America Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 205. Rest of South America Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 206. Rest of South America Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 207. Asia Pacific Cell-Surface Markers, by Country USD Million (2021-2026)
  • Table 208. Asia Pacific Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 209. Asia Pacific Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 210. Asia Pacific Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 211. Asia Pacific Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 212. Asia Pacific Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 213. China Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 214. China Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 215. China Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 216. China Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 217. China Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 218. Japan Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 219. Japan Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 220. Japan Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 221. Japan Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 222. Japan Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 223. India Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 224. India Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 225. India Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 226. India Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 227. India Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 228. South Korea Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 229. South Korea Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 230. South Korea Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 231. South Korea Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 232. South Korea Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 233. Taiwan Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 234. Taiwan Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 235. Taiwan Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 236. Taiwan Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 237. Taiwan Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 238. Australia Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 239. Australia Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 240. Australia Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 241. Australia Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 242. Australia Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 243. Rest of Asia-Pacific Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 248. Europe Cell-Surface Markers, by Country USD Million (2021-2026)
  • Table 249. Europe Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 250. Europe Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 251. Europe Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 252. Europe Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 253. Europe Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 254. Germany Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 255. Germany Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 256. Germany Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 257. Germany Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 258. Germany Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 259. France Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 260. France Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 261. France Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 262. France Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 263. France Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 264. Italy Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 265. Italy Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 266. Italy Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 267. Italy Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 268. Italy Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 269. United Kingdom Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 270. United Kingdom Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 271. United Kingdom Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 272. United Kingdom Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 273. United Kingdom Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 274. Netherlands Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 275. Netherlands Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 276. Netherlands Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 277. Netherlands Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 278. Netherlands Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 279. Rest of Europe Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 280. Rest of Europe Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 281. Rest of Europe Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 282. Rest of Europe Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 283. Rest of Europe Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 284. MEA Cell-Surface Markers, by Country USD Million (2021-2026)
  • Table 285. MEA Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 286. MEA Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 287. MEA Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 288. MEA Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 289. MEA Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 290. Middle East Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 291. Middle East Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 292. Middle East Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 293. Middle East Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 294. Middle East Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 295. Africa Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 296. Africa Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 297. Africa Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 298. Africa Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 299. Africa Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 300. North America Cell-Surface Markers, by Country USD Million (2021-2026)
  • Table 301. North America Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 302. North America Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 303. North America Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 304. North America Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 305. North America Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 306. United States Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 307. United States Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 308. United States Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 309. United States Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 310. United States Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 311. Canada Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 312. Canada Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 313. Canada Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 314. Canada Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 315. Canada Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 316. Mexico Cell-Surface Markers, by Type USD Million (2021-2026)
  • Table 317. Mexico Cell-Surface Markers, by Application USD Million (2021-2026)
  • Table 318. Mexico Cell-Surface Markers, by Reagent Type USD Million (2021-2026)
  • Table 319. Mexico Cell-Surface Markers, by Source USD Million (2021-2026)
  • Table 320. Mexico Cell-Surface Markers, by Cell Type USD Million (2021-2026)
  • Table 321. Cell-Surface Markers: by Type(USD/Units)
  • Table 322. Research Programs/Design for This Report
  • Table 323. Key Data Information from Secondary Sources
  • Table 324. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cell-Surface Markers: by Type USD Million (2015-2020)
  • Figure 5. Global Cell-Surface Markers: by Application USD Million (2015-2020)
  • Figure 6. Global Cell-Surface Markers: by Reagent Type USD Million (2015-2020)
  • Figure 7. Global Cell-Surface Markers: by Source USD Million (2015-2020)
  • Figure 8. Global Cell-Surface Markers: by Cell Type USD Million (2015-2020)
  • Figure 9. South America Cell-Surface Markers Share (%), by Country
  • Figure 10. Asia Pacific Cell-Surface Markers Share (%), by Country
  • Figure 11. Europe Cell-Surface Markers Share (%), by Country
  • Figure 12. MEA Cell-Surface Markers Share (%), by Country
  • Figure 13. North America Cell-Surface Markers Share (%), by Country
  • Figure 14. Global Cell-Surface Markers: by Type USD/Units (2015-2020)
  • Figure 15. Global Cell-Surface Markers share by Players 2020 (%)
  • Figure 16. Global Cell-Surface Markers share by Players (Top 3) 2020(%)
  • Figure 17. Global Cell-Surface Markers share by Players (Top 5) 2020(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 21. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 22. QIAGEN (Germany) Revenue: by Geography 2020
  • Figure 23. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 24. Beckman Coulter (United States) Revenue: by Geography 2020
  • Figure 25. BD (United States) Revenue, Net Income and Gross profit
  • Figure 26. BD (United States) Revenue: by Geography 2020
  • Figure 27. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 29. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 30. Grifols (Spain) Revenue: by Geography 2020
  • Figure 31. Immucor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Immucor, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Janssen Pharmaceutica (Belgium) Revenue, Net Income and Gross profit
  • Figure 34. Janssen Pharmaceutica (Belgium) Revenue: by Geography 2020
  • Figure 35. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Nihon Kohden (Japan) Revenue: by Geography 2020
  • Figure 37. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Roche Holding AG (Switzerland) Revenue: by Geography 2020
  • Figure 39. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Siemens (Germany) Revenue: by Geography 2020
  • Figure 41. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Sysmex Corporation (Japan) Revenue: by Geography 2020
  • Figure 43. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 44. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 45. Global Cell-Surface Markers: by Type USD Million (2021-2026)
  • Figure 46. Global Cell-Surface Markers: by Application USD Million (2021-2026)
  • Figure 47. Global Cell-Surface Markers: by Reagent Type USD Million (2021-2026)
  • Figure 48. Global Cell-Surface Markers: by Source USD Million (2021-2026)
  • Figure 49. Global Cell-Surface Markers: by Cell Type USD Million (2021-2026)
  • Figure 50. South America Cell-Surface Markers Share (%), by Country
  • Figure 51. Asia Pacific Cell-Surface Markers Share (%), by Country
  • Figure 52. Europe Cell-Surface Markers Share (%), by Country
  • Figure 53. MEA Cell-Surface Markers Share (%), by Country
  • Figure 54. North America Cell-Surface Markers Share (%), by Country
  • Figure 55. Global Cell-Surface Markers: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • QIAGEN (Germany)
  • Beckman Coulter (United States)
  • BD (United States)
  • Bio-Rad Laboratories (United States)
  • Grifols (Spain)
  • Immucor, Inc. (United States)
  • Janssen Pharmaceutica (Belgium)
  • Nihon Kohden (Japan)
  • Roche Holding AG (Switzerland)
  • Siemens (Germany)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

Coagulation Reagent Comprehensive Study by Type (APTT, D-Dimer, Fibrinogen, Prothrombin, Others), Application (Hospitals, Research Institutes, Diagnostic Centers, Others), Technology (Mechanical, Ele...
Coagulation Reagent Comprehensive Study by Type (APTT, D-Dimer, Fibrinogen, Prothrombin, Others), Application (Hospitals, Research Institutes, Diagnostic Centers, Others), Technology (Mechanical, Ele...
$ 3800
Biological Sample Handling Comprehensive Study by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, Others), Sample Type (Blood and Blood Fractions...
Biological Sample Handling Comprehensive Study by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, Others), Sample Type (Blood and Blood Fractions...
$ 3800
Biofilms Treatment Comprehensive Study by Type (Biofilm Disruptors, Antimicrobial Treatments, Antibiotic Medication, Photo Inactivation, Others), Application (Hospitals, ASCs, and Wound Care Centers,...
Biofilms Treatment Comprehensive Study by Type (Biofilm Disruptors, Antimicrobial Treatments, Antibiotic Medication, Photo Inactivation, Others), Application (Hospitals, ASCs, and Wound Care Centers,...
$ 3800